Investing in the future of organ transportation – Liontrust
Liontrust looks at how looks US company Transmedics is changing the face of organ transplants.
Posted on Feb 12, 2024
Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article.
Please login or join to view.
Focusing on the theme of ‘Enabling innovation in healthcare’, Sarah Nottle, investment analyst in the Sustainable team, looks at how US company Transmedics is changing the face of organ transplants.
226B Oving Road
Pensions for Purpose acts as an information centre only.
We do not endorse any content published on this website that originated from one of our members.